Difficulty: Medium
Average Score: 87%
Practice
MATCH the pharmacokinetic parameter or term to the appropriate statement. A main determinant of bioavailability (F) following oral administration
Correct answer
D
Rationale
In this question, the correct answer is D) Hepatic extraction. Hepatic extraction refers to the process by which a drug is removed from the blood by the liver before it enters systemic circulation. This is a main determinant of bioavailability (F) following oral administration because drugs that undergo extensive hepatic extraction will have lower bioavailability due to significant first-pass metabolism in the liver.
Option A) Systemic clearance (CLs) is the volume of blood cleared of the drug per unit time. While systemic clearance is an important pharmacokinetic parameter, it is not the main determinant of bioavailability following oral administration.
Option B) Volume of distribution (Vd) is the theoretical volume in which the total amount of drug would need to be uniformly distributed to produce the observed blood concentration. Vd is not directly related to bioavailability.
Option C) Half-life (t1/2) is the time taken for the concentration of the drug in the blood to reduce by half. While half-life is crucial in determining dosing intervals, it is not the main determinant of bioavailability following oral administration.
Understanding pharmacokinetic parameters is essential for predicting how a drug will behave in the body, including absorption, distribution, metabolism, and excretion. Knowing which parameter impacts bioavailability helps healthcare professionals optimize drug therapy and minimize adverse effects.
Option A) Systemic clearance (CLs) is the volume of blood cleared of the drug per unit time. While systemic clearance is an important pharmacokinetic parameter, it is not the main determinant of bioavailability following oral administration.
Option B) Volume of distribution (Vd) is the theoretical volume in which the total amount of drug would need to be uniformly distributed to produce the observed blood concentration. Vd is not directly related to bioavailability.
Option C) Half-life (t1/2) is the time taken for the concentration of the drug in the blood to reduce by half. While half-life is crucial in determining dosing intervals, it is not the main determinant of bioavailability following oral administration.
Understanding pharmacokinetic parameters is essential for predicting how a drug will behave in the body, including absorption, distribution, metabolism, and excretion. Knowing which parameter impacts bioavailability helps healthcare professionals optimize drug therapy and minimize adverse effects.